Anxiety & Social Anxiety: Everything That Actually Helps

Your palms are wet and you haven’t left the house yet. The party starts at seven and you’ve been running the conversational simulations since noon—what to say when you arrive, how to stand, where to put your hands, whether the thing you said to Sarah last Thursday was weird, whether people noticed, whether they’re still thinking about it. They’re not still thinking about it. You know this intellectually. Your amygdala doesn’t care what you know intellectually.

About 40 million adults in the United States live with an anxiety disorder. In Canada, anxiety affects roughly 3 million people. Social anxiety specifically—the flavor that turns other human beings into an obstacle course—sits at around 15 million Americans, making it the third most common mental health condition in the country. And those are the diagnosed numbers. The undiagnosed numbers are anyone’s guess, because one of the hallmarks of social anxiety is avoiding the appointment where someone might diagnose you with it.

If you’re looking for supplements for anxiety that have real clinical evidence behind them—not supplement-industry marketing copy, not anecdotal Reddit threads, but actual peer-reviewed research—this is the most comprehensive guide you’ll find. We’ve tiered everything by the strength of its evidence. We’ve named the studies, the researchers, and the sample sizes. We’ve included what’s overhyped. And at the end, there’s a compound being studied at Johns Hopkins and Imperial College London that most people haven’t considered yet, because it doesn’t live on the supplement shelf.

What’s Actually Happening

Anxiety is not weakness. It is not a personality flaw. It is a threat detection system that won’t turn off.

Your brain runs a security operation centered on a small, almond-shaped structure called the amygdala. The amygdala’s job is survival: scan the environment for threats, trigger a response if one appears. In an anxiety disorder, this system is hypersensitive. It fires at stimuli that aren’t dangerous—a social gathering, an email notification, a silence in conversation that lasted half a second too long. It fires, and it fires fast. Faster than your conscious brain can evaluate whether the threat is real. By the time the prefrontal cortex (the rational, evaluative part of your brain) gets the memo, your heart rate is already up, your cortisol is already spiking, and your body has already decided that this birthday party is a survival scenario.

The HPA axis—hypothalamic-pituitary-adrenal axis—is the chain of command for your stress response. In chronic anxiety, the HPA axis is dysregulated. It over-produces cortisol, the stress hormone, and it does so in response to lower and lower thresholds of provocation. Over time, chronically elevated cortisol shrinks the hippocampus (which is supposed to help contextualize memories and distinguish real threats from perceived ones) and strengthens the amygdala’s wiring. The anxious brain literally remodels itself to be more anxious. This is not metaphor. This is neuroplasticity working against you.

At the neurotransmitter level, two systems are especially relevant:

GABA (gamma-aminobutyric acid) is your brain’s primary inhibitory neurotransmitter—the brakes. It calms neural activity. People with anxiety disorders tend to have lower GABA activity or GABA receptor sensitivity. This is why benzodiazepines (Xanax, Ativan, Klonopin) work so fast: they directly amplify GABA signaling. It’s also why they’re addictive—your brain down-regulates its own GABA production when an external source is doing the work.

Serotonin modulates mood, social behavior, and the amygdala’s threat response. Low serotonin signaling is associated with heightened anxiety, particularly social anxiety. SSRIs work by increasing available serotonin in the synapse. They work for some people. They also come with a timeline (4-6 weeks to onset), side effects (sexual dysfunction, emotional blunting, weight changes), and a dependency pattern that makes discontinuation its own medical event.

For social anxiety specifically, there’s an additional layer: the default mode network (DMN), a brain network that activates during self-referential thinking. In social anxiety, the DMN is hyperactive. It generates a running internal monologue of self-evaluation, prediction, and post-event rumination. This is why social anxiety isn’t just about the event itself—it’s about the three hours before and the three days after. The DMN keeps the tape running.

There’s one more piece. The vagus nerve—the longest cranial nerve in your body, running from your brainstem to your gut—plays a regulatory role in anxiety that’s only recently been appreciated. The vagus nerve mediates parasympathetic (“rest and digest”) activity, and vagal tone—how effectively this nerve functions—is measurably lower in people with anxiety disorders. Low vagal tone means the braking system for your stress response is weak. The alarm fires, and the mechanism that’s supposed to bring you back to baseline is sluggish. This explains why certain interventions that seem unrelated to anxiety—deep breathing, cold exposure, probiotics—can have anxiolytic effects: they improve vagal tone, strengthening the brakes.

The reason this biology section exists in a guide about supplements is simple: if you don’t understand which system is malfunctioning, you can’t evaluate whether a proposed solution addresses the actual problem. Every supplement and intervention on this list targets one or more of these mechanisms. The question isn’t whether something “helps anxiety” in some vague, general way. The question is: which part of this system does it act on, and how strong is the evidence that it actually does?

What the Research Says Works

Strong Evidence: The Foundations

These aren’t supplements—they’re the interventions with the deepest evidence base. If you’re dealing with anxiety and you haven’t addressed these first, supplements are putting a roof on a house that doesn’t have a foundation.

Cognitive Behavioral Therapy (CBT) remains the most evidence-supported psychological treatment for anxiety disorders. A 2012 meta-analysis of 269 studies found large effect sizes for CBT in treating anxiety, with improvements maintained at follow-up (Hofmann et al., Cognitive Therapy and Research). For social anxiety specifically, CBT that includes exposure therapy—gradually facing avoided social situations in a structured way—consistently outperforms medication alone in long-term outcomes. The medication helps while you take it. The CBT rewires how you process social threat signals.

Exercise—specifically aerobic exercise at moderate intensity, 3-5 times per week—produces anxiolytic effects comparable to medication in some studies. A 2015 meta-analysis in the Journal of Psychiatric Research found that regular exercise significantly reduced anxiety symptoms across clinical and non-clinical populations (Stubbs et al., 2017). The mechanism is multi-pronged: exercise reduces cortisol, increases BDNF (brain-derived neurotrophic factor, which supports neuroplasticity), boosts endorphins, and—perhaps most relevant for anxiety—improves interoceptive awareness. You learn to experience an elevated heart rate in a context that isn’t threatening, which gradually recalibrates your brain’s interpretation of physical arousal.

Mindfulness meditation, practiced consistently, reduces amygdala reactivity. A 2013 study at Massachusetts General Hospital found that eight weeks of mindfulness training physically reduced amygdala gray matter density in response to emotional stimuli (Taret et al., Social Cognitive and Affective Neuroscience). For social anxiety, mindfulness targets the DMN rumination cycle directly: by training sustained present-moment attention, it interrupts the self-referential thought loop that makes social situations exhausting.

Strong Supplement Evidence

These supplements have multiple randomized controlled trials, consistent replication, and clear mechanisms of action.

Ashwagandha (Withania somnifera) is an adaptogen that modulates the HPA axis—the cortisol command chain. A landmark 2012 study by Chandrasekhar et al. in the Indian Journal of Psychological Medicine gave 64 adults with chronic stress either 300mg of ashwagandha root extract twice daily or placebo for 60 days. The ashwagandha group showed a 27.9% reduction in serum cortisol—not self-reported stress, not questionnaire scores, but a measurable drop in the hormone that drives the anxiety cascade. Stress-assessment scores improved by 44% compared to 5.5% for placebo. A 2021 systematic review of 12 studies confirmed the pattern across multiple trial designs: ashwagandha consistently reduces anxiety and cortisol in stressed adults.

For social anxiety, the cortisol mechanism is particularly relevant. The anticipatory cortisol spike—the one that starts hours before the social event—is what turns a dinner party into a day-long ordeal. By lowering baseline cortisol, ashwagandha shrinks the spike’s ceiling.

Ashwagandha: full research profile in the Apothecary

L-theanine, the amino acid found in green tea, promotes alpha brain wave activity—the same neural pattern produced during calm, focused states and meditation. A 2019 randomized controlled trial published in Nutrients found that 200mg daily for four weeks significantly reduced stress-related symptoms and improved cognitive function compared to placebo (Hidese et al., 2019). The mechanism is a triple neurotransmitter play: L-theanine simultaneously increases GABA, serotonin, and dopamine. This creates what researchers describe as “relaxed alertness”—calmer without drowsiness. For social situations, this distinction matters enormously. You want to take the edge off, not remove yourself from the conversation.

Worth noting: L-theanine has no known drug interactions, no dependency potential, and no tolerance buildup. You can take it daily, take it situationally, combine it with other anxiolytics, or stack it with your existing SSRI without concern. In the supplement world, that safety profile is unusual for something that actually works.

Typical dosage: 100-200mg, taken 30-60 minutes before a social situation or daily for cumulative effects.

L-theanine: full research profile in the Apothecary

Magnesium—and specifically, the deficiency you likely don’t know you have. An estimated 50% of North Americans consume less than the recommended daily intake. A 2017 systematic review in Nutrients examined 18 studies and found that magnesium supplementation had a significant positive effect on subjective anxiety, particularly in individuals who were already deficient (Boyle et al., 2017). Magnesium acts as a natural calcium channel blocker in the nervous system, calming neuronal excitability and supporting GABA function. It also addresses something most supplements ignore: the physical symptoms. Jaw clenching. Tight shoulders. That inability to take a full breath. When the body unclenches, the mind has less raw material for catastrophizing.

Best forms: magnesium glycinate (best absorption, calming) or magnesium threonate (crosses blood-brain barrier, supports cognition). Skip magnesium oxide—mostly unabsorbed and mostly a laxative.

Passionflower (Passiflora incarnata) earned its spot here with a study that shocked the supplement world. Akhondzadeh et al. (2001) ran a double-blind trial comparing passionflower extract to oxazepam—an actual prescription benzodiazepine—in 36 patients with generalized anxiety disorder. Published in the Journal of Clinical Pharmacy and Therapeutics. The result: passionflower was comparable to oxazepam in reducing anxiety symptoms, with significantly fewer side effects. The oxazepam group had more job-performance impairment. The passionflower group didn’t. A botanical extract went head-to-head with a pharmaceutical anxiolytic and held its ground.

The mechanism is GABAergic—passionflower increases GABA availability, the same neurotransmitter system that benzodiazepines target, but through a gentler modulatory pathway rather than direct receptor agonism. This means anxiolytic effects without the dependency risk, the cognitive fog, or the rebound anxiety that makes benzo withdrawal its own nightmare.

Passionflower: full research profile in the Apothecary

Good Evidence

Fewer trials or smaller sample sizes, but consistent results and plausible mechanisms.

Kava (Piper methysticum) has a 2013 meta-analysis by Sarris et al. in the Journal of Clinical Psychopharmacology that found kava significantly reduced anxiety compared to placebo across 11 trials. The effect size was moderate to large. Kava works on GABA receptors and also modulates dopamine and norepinephrine—a broader mechanism than most anxiolytics. The anxiolytic effects are noticeable within hours, not weeks, which makes it one of the few natural supplements that works acutely. The concern: early reports of liver toxicity led to regulatory action in several countries, though subsequent research suggests the liver risk was largely tied to non-root preparations and pre-existing liver conditions. If you have healthy liver function and use root-based extracts, the safety profile appears reasonable. But it’s worth monitoring, and this is genuinely one of those “talk to your doctor” situations.

Rhodiola rosea is an adaptogen that specifically targets mental fatigue and stress-induced anxiety. Cropley et al. (2015) found that 200mg twice daily for 14 days significantly reduced self-reported anxiety, stress, anger, confusion, and depression in chronically stressed adults. The mechanism involves modulating cortisol and enhancing serotonergic signaling. Rhodiola is particularly interesting for the kind of anxiety that shows up as burnout—the exhaustion-anxiety combination where you’re simultaneously wired and depleted.

Lavender (Silexan)—specifically the standardized lavender oil preparation Silexan—has clinical trial data that most people don’t expect from something that sounds like an aromatherapy product. Kasper et al. (2014) published a multi-center, double-blind trial in the International Journal of Neuropsychopharmacology comparing Silexan 80mg to paroxetine 20mg (a prescription SSRI) in generalized anxiety disorder. Silexan was non-inferior to paroxetine. A lavender oil capsule performed comparably to a prescription antidepressant in a properly designed clinical trial. The catch: this is Silexan specifically, not lavender essential oil from the health food store diffused on your pillow.

Promising: The Emerging Evidence

The early signals here are real but the evidence base is still developing. These deserve attention, not certainty.

Psilocybin microdosing is the compound we’ll cover in depth below, but the positioning matters: it sits in the “promising” tier because the clinical research on microdosing specifically (as opposed to full-dose psilocybin-assisted therapy) is still early. Polito & Stevenson (2019) conducted one of the first systematic studies of microdosers, published in PLOS One, finding decreased mind-wandering and neuroticism with sustained practice. Anderson et al. (2019) found that microdosers reported improved mood and reduced anxiety compared to non-microdosers. The mechanistic basis is plausible: psilocybin’s interaction with 5-HT2A receptors and its effect on default mode network connectivity directly addresses several of the anxiety mechanisms described above. But we need more RCTs before this moves to “strong evidence,” and we’re not going to pretend otherwise.

Lemon balm (Melissa officinalis) has a small number of trials showing anxiolytic and calming effects, likely through GABA transaminase inhibition. Cases et al. (2011) found 600mg daily reduced anxiety manifestations by 18% and insomnia by 42% in a 15-day pilot study. A 2014 study by Scholey et al. found that lemon balm extract reduced laboratory-induced psychological stress. The anxiolytic effect appears to be both acute and cumulative, which is unusual—most supplements work on one timeline or the other. Promising, but the trial sizes remain small and more replication is needed before this moves up a tier.

Probiotics (psychobiotics)—the gut-brain axis connection to anxiety is real, though the intervention data is still maturing. A 2019 meta-analysis by Liu et al. in BMJ Open found that probiotic supplementation significantly reduced anxiety symptoms, though the effect was stronger in clinical populations than in healthy volunteers. The mechanism runs through the vagus nerve: gut microbiome composition affects vagal signaling, which affects parasympathetic regulation, which affects how quickly your nervous system returns to baseline after an anxiety trigger. Specific strains showing anxiolytic properties include Lactobacillus rhamnosus (JB-1) and Bifidobacterium longum (1714). The evidence is promising enough to include here but not strong enough to recommend as a standalone intervention.

Overhyped: Marketing Outpacing Evidence

We’re including this section because honesty requires it, and because the gap between what’s marketed and what’s proven is sometimes a canyon.

CBD for anxiety has become a multi-billion-dollar industry built on surprisingly thin clinical evidence for anxiety specifically. The most-cited study—Zuardi et al. (2017)—used a single acute dose of 300mg before a public speaking test and found reduced anxiety. That’s one study, one situation, one dose. The broader literature is inconsistent, with many studies using doses far higher than commercial products contain. CBD may have anxiolytic properties, but the evidence base is dramatically thinner than the marketing budgets suggest. If CBD has helped you, your experience is real and valid. But the “clinically proven” label that many brands use is, at this point, more aspiration than fact.

Valerian root has been traditionally used for centuries, but the modern clinical evidence for anxiety (as opposed to sleep) is genuinely mixed. A 2006 Cochrane review found insufficient evidence to draw conclusions about valerian for anxiety. Some small trials show modest effects. Others show nothing. The inconsistency may be partly due to variability in preparations—valerenic acid content varies wildly between products. If it works for you, fine. But the evidence doesn’t support the confident claims you’ll see on the bottle.

The One You Probably Haven’t Considered

Psilocybin—the psychoactive compound in certain mushroom species—is in the middle of one of the most remarkable research trajectories in modern psychiatry. And while the headline studies involve full therapeutic doses in clinical settings, there’s a growing body of evidence and an enormous body of real-world experience around microdosing: sub-perceptual doses (typically 50-250mg of dried psilocybin mushroom) taken on a scheduled protocol.

Here’s what makes psilocybin relevant to anxiety specifically, as opposed to just another item on the supplement list:

The default mode network effect. Remember the DMN—the brain network responsible for self-referential rumination, the internal monologue that social anxiety weaponizes? Psilocybin, even at microdose levels, modulates DMN connectivity. The research group at Imperial College London has documented this extensively: psilocybin decreases the rigidity of DMN processing, which functionally means less self-referential looping, less anticipatory catastrophizing, less post-event rumination. The tape still plays. It just doesn’t run on repeat.

The 5-HT2A mechanism. Psilocin (the active metabolite of psilocybin) is a serotonin 5-HT2A receptor agonist. This is the same receptor system that SSRIs indirectly affect by increasing synaptic serotonin—but psilocybin acts on it directly, and with a different downstream cascade that includes increased neuroplasticity markers like BDNF. In anxiety terms: it doesn’t just increase the availability of a calming neurotransmitter. It may help rewire the neural pathways that generate excessive threat responses in the first place.

The observational data. Polito & Stevenson’s 2019 systematic study of microdosers found decreased neuroticism and decreased mind-wandering—two of the psychological signatures most associated with anxiety. Anderson et al. (2019) found that microdosers scored lower on measures of negative emotionality and dysfunctional attitudes compared to non-microdosing controls. A 2021 prospective study by Rootman et al. in Scientific Reports found that microdosers reported greater improvements in mood and anxiety over 30 days compared to non-microdosers, though the study was observational and not placebo-controlled.

What the research hasn’t proven yet: that microdosing is definitively superior to placebo for anxiety in controlled settings. The placebo-controlled microdosing trials that have been published (Szigeti et al., 2021) found that expectation effects were large—people who thought they were microdosing improved regardless of whether they actually were. This doesn’t mean microdosing doesn’t work. It means the placebo response in psychedelic research is enormous, and teasing apart the pharmacological effect from the psychological effect is methodologically challenging.

We’re honest about this because honesty is the entire point of this guide. The mechanistic evidence is strong. The observational data is consistent. The controlled trial data is still catching up. If you’re considering psilocybin microdosing for anxiety, you should know all three of those facts.

One more thing worth noting: psilocybin has no physiological dependency profile. No withdrawal syndrome. No tolerance escalation at microdose levels with proper cycling protocols (typically one day on, two days off, or the Fadiman protocol of one day on, three days off). No sexual side effects. No emotional blunting. No weight gain. No serotonin discontinuation syndrome. These are not small things when you compare the side-effect profile to the pharmaceutical options for anxiety.

The typical microdose is 50-250mg of dried psilocybin mushroom—sub-perceptual, meaning you don’t feel “high.” You feel, by most user accounts, like yourself on a good day. More present, less reactive, less inclined to spiral. The effect on social anxiety specifically is one of the most consistent reports: reduced self-consciousness, reduced post-event rumination, increased comfort with silence and with eye contact.

For a comprehensive overview of how psilocybin compares to pharmaceutical anxiolytics and antidepressants, including mechanism, side effects, dependency, and cost: SSRIs vs Psilocybin Microdosing: The Complete Comparison.

What Real People Say

The clinical data measures averages across populations. Here’s what individuals actually report. These are paraphrased from real user experiences—specific enough to be useful, anonymized for obvious reasons.

“I was prescribed Ativan for years and the withdrawal was worse than the anxiety. I started with ashwagandha and L-theanine together, and after about three weeks, I realized I’d been to two social events without the beforehand spiral. Not anxiety-free—just... the volume was lower.”

“Magnesium glycinate before bed changed more than my sleep. The jaw clenching stopped first. Then the shoulder tension. Then I noticed I wasn’t holding my breath during meetings. I’d been magnesium deficient for who knows how long and nobody tested for it.”

“I microdose every third day. The anxiety isn’t gone—I don’t think that’s the goal. But the rumination after social events, where I’d replay every sentence I said for three days, that mostly stopped. I can go to a dinner party and just... let it be a dinner party.”

“Passionflower tea before a work presentation. I almost didn’t try it because it sounded ridiculous. The physical calm was real—my hands didn’t shake, my voice didn’t thin out. My brain still raced a bit but my body wasn’t confirming the panic, which made the whole thing manageable.”

“Nothing worked until I combined things. CBT gave me the cognitive tools. Exercise lowered the baseline. Ashwagandha smoothed the cortisol spikes. Microdosing quieted the self-criticism. No single thing was the answer. The stack was.”

The Honest Summary

If we were sitting across from a friend who said “I have anxiety and I want to try something natural before going the prescription route,” here’s what we’d actually say:

Start with the foundations. Exercise, sleep, and some form of mindfulness practice. These aren’t sexy recommendations. They don’t come in capsules. They also have the deepest evidence base of anything on this list and they address the root physiology rather than managing symptoms. If you’re not doing these, supplements are working with one hand tied behind their back.

Add ashwagandha and magnesium first. Ashwagandha (300mg KSM-66, twice daily) for the HPA axis and cortisol regulation. Magnesium glycinate (300-400mg, evening) for GABA support and the physical tension symptoms. Both have strong evidence, excellent safety profiles, and relatively fast timelines to effect. Together, they address both the hormonal and neurotransmitter sides of anxiety.

L-theanine for acute situations. 200mg thirty minutes before a social event, a presentation, a flight—whatever your specific trigger is. It’s the closest thing to a natural rescue remedy with actual clinical backing. Pairs well with everything on this list.

Passionflower is underrated. Genuinely. The oxazepam-comparison trial is remarkable and passionflower doesn’t get the attention it deserves, probably because nobody’s spending marketing dollars on it. For generalized anxiety with a strong physical component, it’s worth trying.

If you’re curious about psilocybin microdosing, the mechanistic basis is strong, the observational data is consistent, and the side-effect profile is dramatically better than pharmaceutical anxiolytics. Start with our microdosing guide and the research cited above. Make an informed decision. We think the evidence is going in one direction, and that direction is toward this becoming a standard option. It’s not there yet in the clinical literature, but the trajectory is clear.

What we’d skip: high-dose CBD products marketed specifically for anxiety (the evidence doesn’t justify the price), valerian for daytime anxiety (better suited for sleep, and even there the evidence is mixed), and any supplement that promises to “cure” anxiety. Nothing cures anxiety. Some things make the volume manageable.

One last thing. If your anxiety is severe—if you’re avoiding work, relationships, leaving the house, if you’re having panic attacks, if the anxiety is accompanied by depression or suicidal thoughts—please see a professional. Supplements and microdosing are powerful tools. They are not substitutes for clinical care when clinical care is what’s needed. There is no shame in that, and a good therapist will be interested in the evidence we’ve presented here, not dismissive of it.

Related reading: Best Supplements for Social Anxiety | Depression & Mood: What Actually Helps | SSRIs vs Psilocybin Microdosing

Apothecary deep dives: Ashwagandha | L-Theanine | Passionflower | Psilocybin